Codexis CDXS
NASDAQ CDXS
$1.67 +0.09 (+5.70%)
At close: Aug 21, 2026 · 4:00 PM EDT

Codexis (CDXS) Asset Writedowns and Impairment (2013 - 2025)

Codexis (CDXS) posted quarterly Asset Writedowns and Impairment of -$113000.0 for Q1 2025, down 104.04% quarter-over-quarter from $2.8 million in Q4 2024.

Codexis (CDXS) Asset Writedowns and Impairment (2013 - 2025) Analysis & Trends

Codexis' Asset Writedowns and Impairment history runs 6 years deep, the most recent figure standing at -$113000.0 for Q1 2025.

  • In Q1 2025, Asset Writedowns and Impairment changed N/A year-over-year to -$113000.0; the TTM figure through Dec 2025 stood at -$113000.0 (down 101.65% YoY), while the FY2025 annual figure was -$113000.0, down 101.64% from the prior year.
  • Asset Writedowns and Impairment for Q1 2025 stood at -$113000.0, down from $2.8 million in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $7.7 million in Q3 2023, with the low at -$113000.0 in Q1 2025.
  • The 4-year median for Asset Writedowns and Impairment is $1.2 million (2023), against an average of $2.3 million.
  • The sharpest annual moves came in 2023 and 2024: Asset Writedowns and Impairment jumped 285.85% in 2023, then slumped 49.35% in 2024.
  • Codexis' Asset Writedowns and Impairment stood at $311000.0 in 2022, then surged by 285.85% to $1.2 million in 2023, then soared by 133.33% to $2.8 million in 2024, then slumped by 104.04% to -$113000.0 in 2025.
  • Business Quant data shows CDXS's Asset Writedowns and Impairment at -$113000.0 in Q1 2025, $2.8 million in Q4 2024, and $3.9 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Codexis 152.06 Mn 97.14 Mn 11.40 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 413,000.00
Dec 31, 2025 413,000.00
Mar 31, 2025 -113,000.00
Mar 31, 2025 -113,000.00
Dec 31, 2024 2.80 Mn
Dec 31, 2024 2.80 Mn
Sep 30, 2024 3.90 Mn
Sep 30, 2024 3.90 Mn
Jun 30, 2024 165,000.00
Jun 30, 2024 165,000.00
Dec 31, 2023 1.20 Mn
Dec 31, 2023 1.20 Mn
Sep 30, 2023 7.70 Mn
Sep 30, 2023 7.70 Mn
Dec 31, 2022 311,000.00
Dec 31, 2022 311,000.00
Dec 31, 2014 1.79 Mn
Dec 31, 2014 1.79 Mn
Sep 30, 2014 1.84 Mn
Sep 30, 2014 1.84 Mn